Vale, Cherry Lee T.
HRN: 23-74-95 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/03/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/03/2023
10/10/2023
IV
500 Mg
Q8
Thickly Meconium Stained AF
Checking Final Appropriateness
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes